Additional file 1: Table S1. of Physiciansâ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

Breccia, Massimo; Baccarani, Michele; Rosti, Gianantonio; Cottone, Francesco; Cannella, Laura; Guilhot, FranĂ§ois; Vignetti, Marco; Efficace, Fabio

doi:10.6084/m9.figshare.c.3908344_D1.v1

12955_2017_788_MOESM1_ESM.docx (15.14 kB)

Additional file 1: Table S1. of Physiciansâ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

journal contribution

posted on 2017-10-18, 05:00 authored by Massimo Breccia, Michele Baccarani, Gianantonio Rosti, Francesco Cottone, Laura Cannella, FranĂ§ois Guilhot, Marco Vignetti, Fabio Efficace

Physician characteristics. (DOCX 15Â kb)

History

Usage metrics

Keywords

Chronic myeloid leukemia Line of therapy Tyrosine Kinase inhibitors

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC